Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04649021
Status:
COMPLETED
Last Update Posted:
2022-05-10
First Post:
2020-11-17
Brief Title:
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine BNT162b2 in Chinese Healthy Population
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-17
First Submit QC Date:
November 30 2020
Study First Post Date:
2020-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-09
Last Update Post Date:
2022-05-10
Last Update Post Date Type:
ACTUAL